Wound Clinical Trial
— MxBFlexUPESPOfficial title:
Observational Study to Describe the Utilization of Foam Dressings in Routine Clinical Practice, for the Treatment of Patients With Chronic Wounds in Primary Healthcare Centers in Spain.
The aim of this study is to assess and describe the utilization of Mepilex® Border Flex and other foam dressings available in routine clinical practice in the management of patients with chronic wounds, in order to understand the pattern of use and the frequency of dressing changes in wound management. The study will also allow to gain information about the opinion of the HCPs and the patient's experience concerning wound management with foam dressings. This information may help to understand patient's health care optimization in terms of quality and efficiency.
Status | Recruiting |
Enrollment | 40 |
Est. completion date | May 31, 2024 |
Est. primary completion date | May 31, 2024 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Patients aged 18 years or older. - The patient has been deemed by the HCP to change dressing to Mepilex® Border Flex. - Patients with chronic wounds (wounds that have not reduced in size by more than 40% to 50% or healed within a month) treated with foam dressings, other that Mepilex® Border Flex, according to its intended use at baseline visit for minimum 4 weeks. - Patients with an expectation of wound follow-up of at least 4 weeks. - Patients agree only to have the dressing changed by the HCP. - Patients capable of signing the Informed Consent Form and answer the questions being asked. Exclusion Criteria: - Patients with any applicable contraindication or sensibilization to any of the dressing compounds - Patients with pressure ulcers (PU) stage I, deep tissue injuries or terminal wounds (e.g., fungating wounds) - Patients with wounds whose location and/or aetiology requires a dressing change for reasons that are unrelated to the dressing characteristics such as wounds in the sacral area. - Hospice patients - Patients participating in other studies interfering with this study. |
Country | Name | City | State |
---|---|---|---|
Spain | CS Ciudad Expo - Mairena de Aljarafe | Sevilla | Andalusia |
Lead Sponsor | Collaborator |
---|---|
Molnlycke Health Care AB |
Spain,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Dressing use | Number of dressings used the week before baseline visit compared to the number of dressings used the week before follow-up visit. | 4 weeks | |
Secondary | Wound characteristics | Describe clinical characteristics of chronic wounds that are treated with foam dressings in routine clinical practice by HCP assessment | 4 weeks | |
Secondary | Wound management | Describe the management of chronic wounds in terms of frequency of dressing change, type of dressings used and reason for dressing change | 4 weeks | |
Secondary | Technical Performance (HCP evaluation) | Several questions will be asked to evaluate the technical performance properties of the primary dressing. The following will be assessed by the investigator/designee using no/yes values:
1) Based on this patient, would you recommend Mepilex Border Flex for use in your organisation? All other properties will be assessed by the investigator/designee using a 3-item scale of worse, same, better. These include: Ease of application Ease of removal Ability to conform to wound site Ability to indicate the need for dressing change Ability to stay in place Trauma to the wound bed Ability to indicate the need for dressing change Trauma to the wound bed Trauma to the peri-wound skin Patient concordance Overall dressing performance |
4 weeks | |
Secondary | Patient Experience (PRO) | Patients are asked to rate the dressings in regards their experience
The following questions will be assessed by the investigator/designee using a 1-10 level visual analogue scale for pain: How wound you rate the pain in your wound today? How would you rate the pain when Mepilex Border Flex was removed from your wound today? The following will be assessed by the investigator/designee using no/yes values: *Would you recommend this treatment to a relative or friend? All other properties will be assessed by the investigator/designee using a 4-item scale of very poor, poor, good, very good. These include: How would you rate the comfort of Mepilex Border Flex applied to your wound? How would you rate Mepilex Border Flex used in regards to the ability to stay in place? How would you rate your overall satisfaction regarding wound management (including the properties of Mepilex Border Flex and treatment of your wound) |
4 weeks | |
Secondary | Costs | Estimate the weekly cost per patient associated with the dressings used in wound care episodes and the characteristics of use by evaluating type and size of wound and frequency of dressing change | 4 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT03649308 -
Negative Pressure Wound Therapy Compared to Traditional Care After Skin Grafting
|
N/A | |
Recruiting |
NCT03674749 -
The Effects of Meditation and Hyperbaric Oxygen Therapy on Chronic Wounds
|
N/A | |
Completed |
NCT06464250 -
The Effect of Bundle Approach on Foot Care Behaviors and Diabetic Wound Healing in Patients
|
N/A | |
Withdrawn |
NCT03909503 -
A Case Series Evaluating a Collagen Wound Dressing to Treat Wounds
|
N/A | |
Completed |
NCT05297721 -
Nurses' Level of Knowledge on Skin Tears: A Cross-Sectional Study
|
||
Recruiting |
NCT03386175 -
Efficiency of Negative Pression Therapy With Instillation in the Debridement of Wound
|
||
Active, not recruiting |
NCT04701632 -
Prevalence and Variables Associated With Depression in Subjects With Chronic Wounds Using PHQ-9 as a Screening Tool
|
||
Completed |
NCT05618496 -
Multi-centre, Open-label, First-in-man Study With Epipad Used in Adult Patients
|
N/A | |
Not yet recruiting |
NCT03640871 -
HEAL Study: Healing Results, Efficacy and Acceptability of a New Contact Layer
|
N/A | |
Completed |
NCT02399722 -
Combination of a Polymeric Membrane Dressing Plus Negative Pressure Wound Therapy Against Negative Pressure Wound Therapy Alone
|
N/A | |
Completed |
NCT04507724 -
The Use of Biochemical Analyzes to Monitor the Development of Wounds
|
||
Recruiting |
NCT05556954 -
Diabetic Foot Ulcers Microbiome and Pathogen Identification
|
||
Completed |
NCT03938584 -
The Effect of Vitamin C on Wound Healing In Mandibular Fracture Patients
|
N/A | |
Terminated |
NCT03723603 -
An Evaluation of a Collagen Dressing to Treat Chronic, Stalled Lower-extremity Wounds
|
N/A | |
Completed |
NCT03754426 -
A Prospective, Pilot Evaluation of Device Equivalence
|
||
Recruiting |
NCT02643680 -
Clinical Study of Biocellulose Wound Dressing Containing Silk Sericin and PHMB for STSG Donor Sites
|
Phase 2 | |
Recruiting |
NCT01913132 -
PICO Above Incisions After Vascular Surgery
|
N/A | |
Recruiting |
NCT01347489 -
Cronic Pressure Wounds and Relation With Gender
|
N/A | |
Recruiting |
NCT04621825 -
Post Market Surveillance Study to Confirm Safety and Performance of Silicone PHMB Foam
|
N/A | |
Withdrawn |
NCT03723577 -
An Evaluation of a Fibrillar Collagen Dressing to Treat Chronic, Stalled Lower-extremity Wounds
|
N/A |